Invivyd, Inc. (NASDAQ:IVVD) Q3 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Q3 2025 Invivyd Earnings Conference Call. [Operator Instructions] Please also note today's event is being recorded.
Invivyd Inc. (IVVD)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 20,302,100 | $22,332,310 | 0.04% | |
| 2. | Maverick Capital Lee Ainslie | 18,970,913 | $20,868,004 | +86% | 0.28% |
| 3. | RA Capital Management Peter Kolchinsky | 17,119,096 | $18,831,006 | 0.23% | |
| 4. | Driehaus Capital Richard Driehaus | 10,105,078 | $11,115,586 | 0.08% | |
| 5. | M28 Capital Marc Elia | 9,248,250 | $10,173,075 | 14.96% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.50 | 50,000 | $125,000.00 | 50,000 | 2025-11-19 | Filing | |
| $4.52 | 8,000 | $36,160.00 | 8,000 | 2022-09-01 | Filing | |
| $4.62 | 584,451 | $2,700,163.62 | 9,248,250 | 2022-08-19 | Filing | |
| $4.31 | 1,265,549 | $5,454,516.19 | 8,663,799 | 2022-08-18 | Filing | |
| $4.04 | 1,000,000 | $4,040,000.00 | 7,398,250 | 2022-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.57 | 29,643 | $16,795.72 | 59,344 | 2025-08-19 | Filing | |
| $0.65 | 20,013 | $13,012.45 | 88,987 | 2025-08-18 | Filing | |
| $0.57 | 29,643 | $16,795.72 | 49,344 | 2025-08-19 | Filing | |
| $0.65 | 20,013 | $13,012.45 | 78,987 | 2025-08-18 | Filing | |
| $0.57 | 29,643 | $16,795.72 | 49,344 | 2025-08-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 25,383,077 | $28,048,300 | 0.01% | |
| 2. | 11,241,580 | $12,365,738 | 19.18% | |
| 3. | 5,762,894 | $6,339,184 | 0% | |
| 4. | 812,706 | $893,977 | 0.01% | |
| 5. | 780,127 | $858,139 | 0% |
News See All
Invivyd, Inc. (IVVD) Secures FDA Path for COVID-19 Antibody Approval
Invivyd, Inc. (NASDAQ:IVVD) is a commercial-stage biopharmaceutical company focused on developing antibody-based therapies for serious viral infections, including COVID-19 and influenza.
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
H.C. Wainwright Lowers Invivyd (IVVD) PT to $5 Amid Q1 2025 Revenue Shortfall
On Wednesday, H.C. Wainwright analyst Matthew Hedberg adjusted the price target on Invivyd Inc. (NASDAQ:IVVD) from $10 to $5, while maintaining a Buy rating.
Invivyd, Inc. (NASDAQ:IVVD) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. And welcome to Invivyd’s First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025
No matter the market environment, you’ll always find entertainment in the biotech space.
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025
The healthcare sector is staging a comeback so far in 2025 after two years of underperformance. These stocks could get even hotter due to AI.
12 Best Penny Stocks to Invest in According to the Media
On December 24, Global Advisors’ managing partner, Tom Lee, shared his thoughts on the potential of small and mid-cap stocks in 2025.
Invivyd, Inc. (NASDAQ:IVVD) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q3 2024 Invivyd Earnings Conference Call. At this time, all participants are in a listen-only mode.
Invivyd, Inc. (NASDAQ:IVVD) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Second Quarter Invivyd Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
Hedge Fund Resource Center Billionaire Hedge Funds
